General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-01-03 | 2022-09 | 0 | N/A | N/A | N/A |
2022-10-04 | 2022-06 | 0 | N/A | N/A | N/A |
2022-06-30 | 2022-03 | 0 | N/A | N/A | N/A |
2022-04-05 | 2021-12 | 0 | N/A | N/A | N/A |
2021-11-02 | 2021-09 | -0.01 | 0.01 | 0.02 | 200.00% |
2021-08-03 | 2021-06 | 0 | 0.01 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2021-02-11 | Canaccord Genuity | Upgrade | Hold | |
2020-05-19 | Wells Fargo | Upgrade | Underweight | |
2020-02-26 | Cantor Fitzgerald | Upgrade | Neutral | |
2020-01-08 | Wells Fargo | Downgrade | Equal-Weight | Underweight |
2019-11-20 | Canaccord Genuity | Downgrade | Buy | Hold |
2019-07-31 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-11-16 | BONDURANT WILLIAM | Chief Financial Officer | 355.66K | Sale |
2021-11-16 | CHAN ERIC MING POH | Officer | 126.06K | Sale |
2021-06-29 | COHEN SETH B | Director | 208.61K | Sale |
2021-06-09 | EBERHARD MICHAEL L | Director | 425.81K | Stock Award(Grant) |
2021-07-11 | EBERSMAN DAVID A | Director | 0.00 | Conversion of Exercise of derivative security |
2021-11-16 | O'MEARA MAEVE | Chief Executive Officer | 1.63M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-12-30 | FMR, LLC | 19.77M | 30.45M | 14.78% |
2021-12-30 | Blackrock Inc. | 9.61M | 14.80M | 7.18% |
2021-12-30 | Whetstone Capital Advisors, LLC | 6.56M | 10.11M | 4.91% |
2021-12-30 | Vanguard Group, Inc. (The) | 5.21M | 8.02M | 3.89% |
2021-12-30 | Acadian Asset Management. LLC | 4.50M | 6.93M | 3.36% |
2021-12-30 | Gagnon Securities, LLC | 4.09M | 6.29M | 3.06% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-11-29 | Fidelity Select Portfolios - Medical Technology & Devices Port | 7.75M | 11.86M | 5.80% |
2021-11-29 | Fidelity Select Portfolios - Health Care | 5.00M | 7.65M | 3.74% |
2021-09-29 | Vanguard Total Stock Market Index Fund | 3.13M | 4.92M | 2.34% |
2021-11-29 | iShares Russell 2000 ETF | 2.90M | 4.44M | 2.17% |
2021-11-29 | Fidelity Advisor Health Care Fund | 2.80M | 4.28M | 2.09% |
2021-09-29 | Vanguard Extended Market Index Fund | 1.33M | 2.08M | 0.99% |
So many potential partnerships and customers out there for Castlight to team with, from local governments, to the Federal government, to local health departments, to insurance companies, and to individual companies looking to do be self ensured. That market has to be in excess of $1T. And, if they are using a licensing, the residual yearling income could be staggering.